Lipsia Pharma Private Limited - Company Profile

It is a food and beverages private limited company based in Ghaziabad, Uttar Pradesh, India, established in 2020.
2020 Ghaziabad, Uttar Pradesh, India Active
Last Updated:
Access Report
About Lipsia Pharma Private Limited

Lipsia Pharma Private Limited, a active private limited company, was established on 20 May 2020 in Ghaziabad, Uttar Pradesh, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304UP2020PTC128651. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jonathan Oliver Byrne (Additional Director), Rohit Yadav (Director), Anjali Jindal (Additional Director). Past directors included Vimla Yadav. It is based at 4C / 176, Vartalok Apartment Vasundhara Gzb, Ghaziabad, Uttar Pradesh, 201012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304UP2020PTC128651

  • Registration Number

    128651

  • Incorporation Date

    20 May 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 8 Months
Company report

Lipsia Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lipsia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Lipsia Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jonathan Oliver Byrne Additional Director 12 Oct 2020 Current
Rohit Yadav Director 20 May 2020 Current
Anjali Jindal Additional Director 12 Oct 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Oct 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lipsia Pharma.

Enhance accessibility to Lipsia Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Lipsia Pharma revenue growth over time
Lipsia Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lipsia Pharma?

Unlock access to Lipsia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lipsia Pharma?

Lipsia Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lipsia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lipsia Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lipsia Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Jonathan Oliver Byrne was appointed as a Additional Director was appointed as a Additional Director on 12 Oct 2020 & has been associated with this company since 5 years 4 months . was documented.

  • Director Appointment

    The activity Anjali Jindal was appointed as a Additional Director was appointed as a Additional Director on 12 Oct 2020 & has been associated with this company since 5 years 4 months . was completed.

  • Director Appointment

    Progress on Rohit Yadav was appointed as a Director was appointed as a Director on 20 May 2020 & has been associated with this company since 5 years 8 months . was documented.

  • Company Incorporation

    Progress on Lipsia Pharma Private Limited was registered on 20 May 2020 with Roc Kanpur & aged 5 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lipsia Pharma Private Limited?

The CIN of Lipsia Pharma Private Limited is U24304UP2020PTC128651.

Where is Lipsia Pharma Private Limited headquartered?

Lipsia Pharma Private Limited is headquartered at 4C / 176, Vartalok Apartment Vasundhara Gzb, Ghaziabad, Uttar Pradesh, 201012.

When was Lipsia Pharma Private Limited incorporated?

Lipsia Pharma Private Limited was incorporated on 20 May 2020.

Who are the current directors of Lipsia Pharma Private Limited?

The current directors of Lipsia Pharma Private Limited are

What is the primary industry of Lipsia Pharma Private Limited?

The primary industry of Lipsia Pharma Private Limited is Food And Beverages.

Is Lipsia Pharma Private Limited a listed company?

Lipsia Pharma Private Limited is unlisted.

What is the capital structure of Lipsia Pharma Private Limited?

The authorized capital of Lipsia Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available